NO20054875L - Syntese av 2-klormetyl-6-metylbenzosyreestere - Google Patents

Syntese av 2-klormetyl-6-metylbenzosyreestere

Info

Publication number
NO20054875L
NO20054875L NO20054875A NO20054875A NO20054875L NO 20054875 L NO20054875 L NO 20054875L NO 20054875 A NO20054875 A NO 20054875A NO 20054875 A NO20054875 A NO 20054875A NO 20054875 L NO20054875 L NO 20054875L
Authority
NO
Norway
Prior art keywords
synthesis
chloromethyl
acid esters
methylbenzoic acid
alkyl
Prior art date
Application number
NO20054875A
Other languages
English (en)
Other versions
NO20054875D0 (no
Inventor
Richard Bicker
Claus-Juergen Maier
Tobias Metzenthin
Joachim Graeser
Javier Manero
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20054875D0 publication Critical patent/NO20054875D0/no
Publication of NO20054875L publication Critical patent/NO20054875L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/307—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Sammendrag Det beskrives en fremgangsmåte for fremstilling av forbindelser med formel (I) hvor R betyr H, eventuelt med halogen substituert alkyl, cykloalkyl, aryl, alkyl-aryl eller heteroaryl og i alkyl og cykloalkyl kan en eller flere CH2-grupper være erstattet med -O-. Forbindelsene av formel (I) er verdifulle mellomprodukter ved syntesen av PPAR-agonister.
NO20054875A 2003-03-25 2005-10-21 Syntese av 2-klormetyl-6-metylbenzosyreestere NO20054875L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10313228A DE10313228A1 (de) 2003-03-25 2003-03-25 Synthese von 2-Chlormethyl-6-methylbenzoesäureestern
PCT/EP2004/002579 WO2004085377A1 (de) 2003-03-25 2004-03-12 Synthese von 2-chlormethyl-6-methylbenzoesäureestern

Publications (2)

Publication Number Publication Date
NO20054875D0 NO20054875D0 (no) 2005-10-21
NO20054875L true NO20054875L (no) 2005-12-27

Family

ID=33015963

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054875A NO20054875L (no) 2003-03-25 2005-10-21 Syntese av 2-klormetyl-6-metylbenzosyreestere

Country Status (24)

Country Link
EP (1) EP1611083B1 (no)
JP (1) JP4510805B2 (no)
KR (1) KR20050116388A (no)
CN (1) CN100378065C (no)
AR (1) AR043752A1 (no)
AT (1) ATE374742T1 (no)
AU (1) AU2004224177B2 (no)
BR (1) BRPI0408653A (no)
CA (1) CA2519715A1 (no)
CO (1) CO5690546A2 (no)
CY (1) CY1107029T1 (no)
DE (2) DE10313228A1 (no)
DK (1) DK1611083T3 (no)
ES (1) ES2293237T3 (no)
IL (1) IL171031A (no)
MX (1) MXPA05010001A (no)
NO (1) NO20054875L (no)
NZ (1) NZ542603A (no)
PL (1) PL1611083T3 (no)
PT (1) PT1611083E (no)
RU (1) RU2345982C2 (no)
TW (1) TW200502213A (no)
WO (1) WO2004085377A1 (no)
ZA (1) ZA200506499B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005029382B3 (de) * 2005-06-24 2006-12-21 Sanofi-Aventis Deutschland Gmbh Alkoxymethylyl-substituierte Benzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
CN114805120A (zh) * 2022-05-23 2022-07-29 江苏瑞达环保科技有限公司 一种间氰甲基苯甲酸甲酯的合成工艺
CN118164940A (zh) * 2024-03-15 2024-06-11 江苏盈科工程设计研究有限公司 一种苯酞的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689425A (en) * 1986-11-06 1987-08-25 Stauffer Chemical Company Photochlorination of aromatic compounds in the side chain
PL339660A1 (en) * 1997-10-02 2001-01-02 Sankyo Co Derivatives of amidocarboxylic acids
NZ515087A (en) * 1999-04-28 2003-11-28 Aventis Pharma Gmbh Tri-aryl acid derivatives as PPAR receptor ligands
HRP20010795A2 (en) * 1999-04-28 2003-02-28 Aventis Pharma Gmbh Di-aryl acid derivatives as ppar receptor ligands
BR0212158A (pt) * 2001-08-31 2004-07-13 Aventis Pharma Gmbh Derivados de diarilcicloalquila, processos para a sua preparação e sua aplicação como ativadores de ppar

Also Published As

Publication number Publication date
ES2293237T3 (es) 2008-03-16
ATE374742T1 (de) 2007-10-15
AR043752A1 (es) 2005-08-10
NO20054875D0 (no) 2005-10-21
MXPA05010001A (es) 2005-11-17
RU2005132827A (ru) 2006-02-10
DE10313228A1 (de) 2004-10-21
AU2004224177B2 (en) 2010-01-21
PT1611083E (pt) 2007-11-26
AU2004224177A1 (en) 2004-10-07
NZ542603A (en) 2007-12-21
CY1107029T1 (el) 2012-09-26
EP1611083A1 (de) 2006-01-04
CN1759092A (zh) 2006-04-12
DE502004005137D1 (en) 2007-11-15
IL171031A (en) 2010-11-30
JP2006521307A (ja) 2006-09-21
JP4510805B2 (ja) 2010-07-28
WO2004085377A1 (de) 2004-10-07
DK1611083T3 (da) 2008-01-21
CO5690546A2 (es) 2006-10-31
TW200502213A (en) 2005-01-16
HK1087098A1 (zh) 2006-10-06
ZA200506499B (en) 2006-07-26
BRPI0408653A (pt) 2006-03-07
RU2345982C2 (ru) 2009-02-10
EP1611083B1 (de) 2007-10-03
CN100378065C (zh) 2008-04-02
PL1611083T3 (pl) 2008-01-31
KR20050116388A (ko) 2005-12-12
CA2519715A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
CY1107555T1 (el) Μεθοδος για την βιομηχανικη παρασκευη παραγωγων κινολινης
CY1109225T1 (el) ΠΑΡΑΓΩΓΑ ΜΗΛΟΝΑΜΙΔΙΟΥ ΤΑ ΟΠΟΙΑ ΠΑΡΕΜΠΟΔΙΖΟΥΝ ΤΗ ΔΡΑΣΗ ΤΗΣ γ-ΣΕΚΡΕΤΑΣΗΣ
ATE145891T1 (de) Verfahren zur herstellung von alkoxyiminoacetamid-derivaten und ein zwischenproduckt dafür
BR9910326A (pt) Processo para preeparar isoxazóis, composto, processo para preparar compostos, uso de compostos, e, processo para preparar tioéteres
ATE499620T1 (de) Copolymerisierbare azoverbindungen und artikel damit
NO20051051L (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme i terapeutiske midler
KR890014486A (ko) N-시클로프로필아닐, 및 1-시클로프로필-퀴놀론카르복실산 및 그의 유도체의 제조에 있어서 n-시클로프로필아닐린의 용도
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
EA200701470A1 (ru) Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений
NO20002490D0 (no) FremgangsmÕte for fremstilling av 1,4-dihydropyridiner og forbindelser anvendt ved denne fremgangsmÕten
ATE428693T1 (de) Prostaglandinsynthese
NO20062602L (no) A new process for preparation of imipenem
EA199900528A1 (ru) Новые производные эритромицина, способ их получения и применения в качетве медикаментов
CY1107029T1 (el) Συνθεση 2-χλωρομεθυλο-6-μεθυλοβενζοϊκων εστερων
AR043624A1 (es) Procedimiento para preparar 2-ciano-3-hidroxi-n- (fenil) but-2-enamidas
CY1108075T1 (el) Διαδικασια για την παρασκευη αλκοξυκαρβονυλμεθοξυ-κυκλοπεντανιων
NO20064902L (no) Imidazopyridinforbindelse
NO20055924L (no) Metode for fremstilling av (2s)-3-(4- {2-[Amino]-2-Oksoetoksy}Fenyl)-2-Etoksypropansyrederivater
JP2005510614A5 (no)
NO20070610L (no) Fremgangsmate for fremstilling av synteseintermediater anvendelige ved fremstilling av pyrazolforbindelser.
NO20071996L (no) Framgangsmate for esterifisering av karbothiotisk syre
DK1603868T3 (da) Fremgangsmåde til fremstilling af alfa-(3-arylthio)-acetophenoner
NO20072520L (no) Novel intermediates, process for their preparation and synthesis of 1,4-benzoquinones
CY1108903T1 (el) Διεργασια για την παραγωγη υποκατεστημενων εστερων νικοτινικου οξεος
ATE260264T1 (de) Verfahren zur herstellung von oxazol-derivaten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application